NA Proactive news snapshot: Nemaura Medical, CytoDyn, CB2 Insights, Orgenesis …

Nemaura Medical Inc (NASDAQ:NMRD), a UK-based company focused on diabetes, announced Monday that it is planning to launch a digital healthcare subscription service in the US under the brand name proBEAT. The company said that proBEAT is expected to be available without the need for a prescription and appeal to a broad range of adults encompassing pre-diabetic and Type 2 diabetics - 88 million and 26 million people, respectively - as well as those seeking to lose weight and have a healthier lifestyle. CytoDyn Inc (OTCMKTS:CYDY) announced Monday that three more critically ill coronavirus (COVID-19) patients have been treated with the company’s drug leronlimab, bringing the number of patients treated with it to ten. The use of leronlimab, which has other therapeutic indications as a treatment for HIV and certain breast cancers, is being administered under an emergency Investigational New Drug Application (IND) recently granted by the US Food and Drug Administration (FDA). The new patients, like the seven before them, are being treated at a leading New York City hospital, the company said. CB2 Insights Inc (CSE:CBII) (OTMKTS:CBIIF), the medical cannabis research, data and education group, has extended the reach of its business with the launch of a new interactive dashboard for use by stakeholders. The dashboard, accessed via the firm's website at https://cb2insights.ca/data, is free and offers key patient insights derived from the firm's clinical operations. It was created to answer hundreds of questions from global industry stakeholders, including government agencies and major research groups. It also allows users to submit additional data requests directly to CB2's research and data team. Orgenesis Inc's (NASDAQ:ORGS) CEO Vered Caplan told shareholders Monday that its research and development labs are still operating during the coronavirus (COVID-19) pandemic. “We are leveraging all our knowledge and expertise in the field of cell and gene therapy, including anti-viral technologies relevant to COVID-19. We look forward to providing further updates on this front in the very near future,” Caplan said in a statement. Humanigen Inc (OTCMKTS:HGEN) shares rose on Monday as it announced that it will partner with contract research organization, CTI Clinical Trial and Consulting Services (CTI) on a Phase III clinical trial for lenzilumab to help coronavirus (COVID-19) patients, if a study is approved. The biotech's monoclonal antibody lenzilumab is aimed at treating cytokine storm, which can lead to acute respiratory distress syndrome (ARDS), which is associated with the current deadly form of COVID-19. Loop Insights Inc (CVE:MTRX) said Monday it is launching a new initiative to help retailers and hospitality storefronts land on their feet after the coronavirus pandemic eases. The new initiative, called “Sharing is Caring,” is designed for small business owners facing uncertainty after most governments mandated non-essential retail and food establishments to close their doors in an effort to halt the spread of the virus. Vancouver-based Loop is offering a free three-part webinar series to discuss the state of the retail industry and share ways that business owners can prepare for the eventual reopening of physical stores. GR Silver Mining Ltd (CVE: GRSL (OTCQB:GLYXF) has completed its acquisition of the past-producing Plomosas silver project in Mexico, giving it a commanding position and potential to expand in the exciting Rosario mining district. The vendor is major silver producer First Majestic Silver Corp (NYSE:AG) (TSE:FR), which becomes the group's largest strategic shareholder with a 19.9% holding. Japan Gold Corp (CVE:JG) (OTCQB:JGLDF) announced on Monday that it is shuffling its executive team. The Vancouver-based mineral explorer announced that president Michael Andrews and executive vice president John Carlile have resigned to pursue other opportunities. Meanwhile, Rafaela Vartuli is joining the firm as its new corporate communications manager, the company said. Parallax Health Sciences Inc (OTCMKTS:PRLX) said Monday that its subsidiary, Parallax Diagnostics Inc, has executed a joint venture supply chain agreement with the United States Marine Corps veteran-owned medical device company SAGICO USA for coronavirus (COVID-19) and personal protection equipment (PPE), from FDA-registered manufacturers. SAGICO USA has a long track-record for getting US Food and Drug Administration (FDA) clearances, and other regulatory approvals for the distribution of medical products to government hospitals globally. The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCQX:TGODF) announced Monday that its Ancaster processing facility is ready to begin production after receiving approval of a license amendment from Health Canada. The facility expansion at Ancaster includes dedicated areas for the packaging of flower, oils, pre-rolls, as well as Cannabis 2.0 edible and ingestible products. Dunnedin Ventures Inc (CVE:DVI) (OTCMKTS:OTCFF) has confirmed that its name change to Kodiak Copper Corp will officially take place on Wednesday, April 1. In a statement, the copper-focused resource group said it has now received all necessary approvals and shares under the new name will start trading on Toronto's Venture Exchange under the ticker symbol 'KDK' on that date. The new shares have been consolidated on the basis of one new post-consolidation share for every five pre-consolidation shares. eWellness Healthcare Corporation (OTCQB:EWLL) announced Monday that a number of major health insurers including UnitedHealthcare, CIGNA, Anthem Blue Cross and Blue Shield of California have moved to make digital physical therapy fully reimbursable.  As many physical therapists (PTs) are currently unable to meet with patients in person due to the coronavirus (COVID-19), telemedicine options like eWellness’ PHIZIO program allow them to provide assessment and treatment in real-time using a smartphone or laptop. Fura Gems Inc (CVE:FURA) (OTCMKTS:FUGMF) is extending the drop-dead date for its acquisition of ruby assets in Mozambique, the group said on Monday. The Toronto-based company said it gave New Energy Minerals Ltd written notice on March 26 to extend the date from March 31, 2020, to June 30, 2020. The acquisition gives Fura interests in three ruby licenses in Mozambique. Great Bear Resources Ltd (CVE:GBR) (OTCMKTS:GTBDF), the Red lake gold explorer, has begun mailing shareholders details of a special meeting to vote for the, previously announced, planned spin-out of subsidiary Great Bear Royalties Corp into a separate company. The meeting is to be held on April 23 at 1pm (PST) at the offices of Blake, Cassels & Graydon LLP, Burrard Street, Vancouver. Immunoprecise Antibodies Ltd (CVE:IPA) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 1,244,792 shares at a deemed price of 60 cents to four arm's-length creditors to settle outstanding debt for $746,875. NexTech AR Solutions Corp (OTCMKTS:NEXCF), based in Toronto Ontario, announced that Evan Gappelberg, CEO, will present live at VirtualInvestorConferences.com on Thursday, April 2 at 10:30 am EST via the link: https://tinyurl.com/April2TechVIC. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. Investors can learn more about the event at www.virtualinvestorconferences.com